BACKGROUND: Postoperative outcomes of patients undergoinglaparoscopic-assisted colectomy (LAC) have shown modest improvements in recovery but only minimal differences in quality of life (QOL) compared with open colectomy. We therefore sought to assess the effect of LAC on QOL in the short and long term, using individual item analysis of multi-item QOL assessments. METHODS:QOL variables were analyzed in 449 randomized patients from the COST trial 93-46-53 (INT 0146). Both cross-sectional single-time and change from baseline assessments were run at day 2, week 2, month 2, and month 18 postoperatively in an intention-to-treat analysis using Wilcoxon rank-sum tests. Stepwise regression models were used to determine predictors of QOL. RESULTS: Of 449 colon cancer patients, 230 underwent LAC and 219 underwentopen colectomy. Subdomain analysis revealed a clinically moderate improvement from baseline for LAC in total QOL index at 18 months (P = 0.02) as well as other small symptomatic improvements. Poor preoperative QOL as indicated by a rating scale of ≤ 50 was an independent predictor of poor QOL at 2 months postoperatively. QOL variables related to survival were baseline support (P = 0.001) and baseline outlook (P = 0.01). CONCLUSIONS: Eighteen months after surgery, any differences in quality of life between patients randomized to LAC or open colectomy favored LAC. However, the magnitude of the benefits was small. Patients with poor preoperative QOL appear to be at higher risk for difficult postoperative courses, and may be candidates for enhanced ancillary services to address their particular needs.
RCT Entities:
BACKGROUND: Postoperative outcomes of patients undergoing laparoscopic-assisted colectomy (LAC) have shown modest improvements in recovery but only minimal differences in quality of life (QOL) compared with open colectomy. We therefore sought to assess the effect of LAC on QOL in the short and long term, using individual item analysis of multi-item QOL assessments. METHODS: QOL variables were analyzed in 449 randomized patients from the COST trial 93-46-53 (INT 0146). Both cross-sectional single-time and change from baseline assessments were run at day 2, week 2, month 2, and month 18 postoperatively in an intention-to-treat analysis using Wilcoxon rank-sum tests. Stepwise regression models were used to determine predictors of QOL. RESULTS: Of 449 colon cancerpatients, 230 underwent LAC and 219 underwent open colectomy. Subdomain analysis revealed a clinically moderate improvement from baseline for LAC in total QOL index at 18 months (P = 0.02) as well as other small symptomatic improvements. Poor preoperative QOL as indicated by a rating scale of ≤ 50 was an independent predictor of poor QOL at 2 months postoperatively. QOL variables related to survival were baseline support (P = 0.001) and baseline outlook (P = 0.01). CONCLUSIONS: Eighteen months after surgery, any differences in quality of life between patients randomized to LAC or open colectomy favored LAC. However, the magnitude of the benefits was small. Patients with poor preoperative QOL appear to be at higher risk for difficult postoperative courses, and may be candidates for enhanced ancillary services to address their particular needs.
Authors: Kerry S Courneya; Roanne J Segal; Robert D Reid; Lee W Jones; Shawn C Malone; Peter M Venner; Matthew B Parliament; Chris G Scott; H Arthur Quinney; George A Wells Journal: J Clin Epidemiol Date: 2004-06 Impact factor: 6.437
Authors: Antonio M Lacy; Juan C García-Valdecasas; Salvadora Delgado; Antoni Castells; Pilar Taurá; Josep M Piqué; Josep Visa Journal: Lancet Date: 2002-06-29 Impact factor: 79.321
Authors: Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota Journal: N Engl J Med Date: 2004-05-13 Impact factor: 91.245
Authors: Yingwei Qi; Steven E Schild; Sumithra J Mandrekar; Angelina D Tan; James E Krook; Kendrith M Rowland; Yolanda I Garces; Gamini S Soori; Alex A Adjei; Jeff A Sloan Journal: J Thorac Oncol Date: 2009-09 Impact factor: 15.609
Authors: Kjartan Stormark; Kjetil Søreide; Jon Arne Søreide; Jan Terje Kvaløy; Frank Pfeffer; Morten T Eriksen; Bjørn S Nedrebø; Hartwig Kørner Journal: Surg Endosc Date: 2016-02-23 Impact factor: 4.584
Authors: Rachelle N Damle; Christopher W Macomber; Julie M Flahive; Jennifer S Davids; W Brian Sweeney; Paul R Sturrock; Justin A Maykel; Heena P Santry; Karim Alavi Journal: J Am Coll Surg Date: 2014-03-12 Impact factor: 6.113
Authors: Joseph C Carmichael; Deborah S Keller; Gabriele Baldini; Liliana Bordeianou; Eric Weiss; Lawrence Lee; Marylise Boutros; James McClane; Scott R Steele; Liane S Feldman Journal: Surg Endosc Date: 2017-08-03 Impact factor: 4.584
Authors: Jeroen L A van Vugt; Kostan W Reisinger; Joep P M Derikx; Djamila Boerma; Jan H M B Stoot Journal: World J Gastroenterol Date: 2014-09-21 Impact factor: 5.742
Authors: Janet Baack Kukreja; Qiuling Shi; Courtney M Chang; Mohamed A Seif; Brandon M Sterling; Ting-Yu Chen; Kelly M Creel; Ashish M Kamat; Colin P Dinney; Neema Navai; Jay B Shah; Xin Shelley Wang Journal: Surg Innov Date: 2018-03-20 Impact factor: 2.058
Authors: Juliane Bingener; Jeff A Sloan; Paul J Novotny; Barbara A Pockaj; Heidi Nelson Journal: J Gastrointest Surg Date: 2014-08-05 Impact factor: 3.452
Authors: M Zimmermann; C Benecke; C Jung; M Hoffmann; J Nolde; E Schlöricke; H P Bruch; T Keck; T Laubert Journal: Int J Colorectal Dis Date: 2016-05-02 Impact factor: 2.571